Skip to main content
SpringerLink
Log in

Diabetes mellitus after kidney transplantation: Role of the impaired fasting glucose in the outcome of kidney transplantation

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Introduction: Most patients suffering from chronic renal insufficiency show impaired carbohydrate metabolism. Our goals were to analyze the accumulated incidence of impaired fasting glucose (IFG) and post-transplant diabetes mellitus (PTDM) after kidney transplantation in our hospital, to assess their impacts on the survival of the graft and of the patient, and to discover the major risk factors for the development of PTDM. Materials and methods: We examined alterations in carbohydrate metabolism in 920 adult patients after they received kidney transplantation. Patients were followed for a minimum period of 5 yr. Results: One year after transplantation, 12.8% of the patients had developed PTDM, and 10.3% showed an IFG level. The IFG had a negative and statistically significant influence on graft and patient survival. Host and donor age, weight, hepatitis C virus infection, and acute rejection were found to be significant risk factors. Discussion: Our study found a high incidence of PTDM, as described in previous studies, but with an emphasis on a greater role played by IFG, not only in its incidence, but also as a prognostic factor for the outcome of graft and patient survival. Identifying patients at risk of developing PTDM is important in offering them early and appropriate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sato T, Inagaki A, Uchida K, et al. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 2003, 76: 1320–6.

    Article  PubMed  CAS  Google Scholar 

  2. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003, 3: 178–85.

    Article  PubMed  Google Scholar 

  3. Johny KV, Nampoory MR, Costandi JN, et al. High incidence of post-transplant diabetes mellitus in Kuwait. Diabetes Res Clin Pract 2002, 55: 123–30.

    Article  PubMed  CAS  Google Scholar 

  4. Muhlestein JB, Anderson JL, Home BD, et al; Intermountain Heart Collaborative Study Group. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 2003, 146: 351–8.

    Article  PubMed  CAS  Google Scholar 

  5. Lecomte P, Vol S, Caces E, et al. Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioural risk factors. Diabetes Metab 2002, 28: 311–20.

    PubMed  CAS  Google Scholar 

  6. Bjørnholt J, Erikssen G, Aaser E, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 1999, 22: 45–9.

    Google Scholar 

  7. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained is-chemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000, 11: 1735–43.

    PubMed  CAS  Google Scholar 

  8. Cosio FG, Pesavento TE, Osei K, Henry M, Ferguson RM. Posttransplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001, 59: 732–7.

    Article  PubMed  CAS  Google Scholar 

  9. Hur KY, Kim MS, Kim YS, et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 2007, 30: 609–15.

    Article  PubMed  Google Scholar 

  10. Alebiosu OC, Ayodele OE. Natural history and epidemiology of post transplantation diabetes mellitus. Afr Health Sci 2005, 5: 255–60.

    PubMed Central  PubMed  Google Scholar 

  11. Jindal RM, Hjelmesaeth J. Impact and management of posttrans-plant diabetes mellitus. Transplantation 2000, 70: SS58–63.

    PubMed  CAS  Google Scholar 

  12. Montori V, Basu A, Erwin P, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002, 25: 583–92.

    Article  PubMed  Google Scholar 

  13. Davidson JA, Wilkinson A. International Expert Panel on New-Onset Diabetes after Transplantation. New-Onset Diabetes after Transplantation 2003 International Consensus Guidelines: an endocrinologist’s view. Diabetes Care 2004, 27: 805–12.

    Article  PubMed  Google Scholar 

  14. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Posttransplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clinical studies. Am J Transplant 2005, 5: 2433–40.

    Article  PubMed  Google Scholar 

  15. Marin M, Renoult E, Bondor C, Kessler M. Factors Influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience. Transplant Proc 2005, 37: 1851–6.

    Article  PubMed  CAS  Google Scholar 

  16. Weir MR, Fink JC. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999, 34: 1–13.

    Article  PubMed  CAS  Google Scholar 

  17. Vincenti F, Friman S, Scheuermann E, et al; DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007, 7: 1506–14.

    Article  PubMed  CAS  Google Scholar 

  18. Lucey MR, Abdelmalek MF, Gagliardi R, et al. A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant 2005, 5: 1111–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, University Hospital La Fe, Valencia, Spain

    M. A. Mollar-Puchades, J. F. Merino-Torres & F. Piñón-Sellés

  2. Department of Nephrology, University Hospital La Fe, Valencia, Spain

    T. Malek-Marin, D. Ramos-Escorihuela & J. Sánchez-Plumed

Authors
  1. M. A. Mollar-Puchades
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Malek-Marin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. F. Merino-Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Ramos-Escorihuela
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Sánchez-Plumed
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Piñón-Sellés
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. F. Merino-Torres.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mollar-Puchades, M.A., Malek-Marin, T., Merino-Torres, J.F. et al. Diabetes mellitus after kidney transplantation: Role of the impaired fasting glucose in the outcome of kidney transplantation. J Endocrinol Invest 32, 263–266 (2009). https://doi.org/10.1007/BF03346464

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346464

Key-words

Search

Navigation